Document is current
Any future updates will be listed below
-
Authors
King, Amanda L.
Roche, Kayla N.
Leeper, Heather E.
Vera, Elizabeth
Mendoza, Tito
Mentges, Kelly
Acquaye-Mallory, Alvina A.
Adegbesan, Kendra A.
Boris, Lisa
Burton, Eric
Choi, Anna
Grajkowska, Ewa
Kunst, Tricia
Levine, Jason
Lollo, Nicole
Miller, Hope
Panzer, Marissa
Penas-Prado, Marta
Pillai, Valentina
Polskin, Lily
Reyes, Jennifer
Sahebjam, Solmaz
Stockdill, Macy L.
Theeler, Brett J.
Wu, Jing
Gilbert, Mark R.
Armstrong, Terri S.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04301089 at ClinicalTrials.govDocuments that mention this clinical trial
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
https://doi.org/10.1007/s11060-023-04271-0
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Cancer Institute, National Institutes of Health
Intramural Continuing Umbrella of Research Experiences
- License Information
-
More Information
Article History
Received: 27 January 2023
Accepted: 15 February 2023
First Online: 8 March 2023
Declarations
:
: The authors have no commercial or financial conflicts of interest to declare related to this study.
: This study protocol has been reviewed and approved by the NIH Institutional Review Board.
: Patients are informed that there is no obligation to participate in this study and there will be no negative impacts on their clinical care should they choose not to take part. If patients choose to participate, they are informed that they can discontinue participation at any time and for any reason. Traditional dissemination methods (i.e. publications in peer-reviewed journals and conference presentations) will be utilized to disseminate findings of this study.
